Executive Change · Reg FD Disclosure

Tenaya Therapeutics, Inc. announced the appointment of Eric Hyllengren as Chief Financial Officer, who will also serve as Principal Financial Officer and Principal Accounting Officer, effective July 13, 2026. This appointment leads to the transition of the interim Principal Financial Officer and acting interim Principal Accounting Officer roles.